ArticleACS omega2024

Retraction of "Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2".

Ming-Feng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.